CareDx (CDNA) Stock Price, Quote, News & History | Benzinga

SPY770.73+0.22%QQQ722.85+0.73%BTC/USD83,028.00+0.11%DIA524.31−0.01%GLD377.24−0.11%TLT79.93−0.25%

CareDx Inc (CDNA) Stock Price, Quote, News & History

CDNANASDAQ

Trade with Public

Trade with Public

$69.20

2.123.16%

Last update: Oct 20, 6:47 PM

$69.99

2.914.34%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$67.20

Close

$69.20

Volume / Avg.

1.56M / 1.27M

Day Range

$65.89 - $70.81

52 Wk Range

14.03 - 72.51

Market Cap

$3.62B

P/E Ratio

32.25

Dividend Yield

-

Exchange

NASDAQ

RSI

71

Short Interest

12.97%

Days to Cover

4.56

Recent CareDx, Inc. News

Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up

Cathie Wood's ARK dumps $18M of Twist Bioscience while buying Recursion, Veracyte and Intellia, extending its CRISPR bet to 50 sessions.

Chandrima Sanyal

Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently

CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.

Vandana Singh

CNH Industrial Posts Upbeat Q2 Earnings, Joins Autolus Therapeutics, Bowhead Specialty Holdings And Other Big Stocks Moving Higher On Monday

Dow Jones index gained 600 points, CNH Industrial rose 16% after reporting better-than-expected Q2 results, other stocks also recording gains.

Avi Kapoor

Why Is CareDx Stock Skyrocketing Thursday?

CareDx ($CDNA) shares surge 28% as Medicare finalizes continued coverage for its kidney, heart, and lung transplant tests.

Vandana Singh

Abbott Laboratories, AtaiBeckley, ManpowerGroup And Other Big Stocks Moving Higher On Thursday

U.S. stocks mixed, Nasdaq falls 150 points. Abbott Labs beats Q2 estimates and raises guidance, stock jumps 12.1%. Other big gainers include ATAI, MAN, DSGR, CDNA, MAAS, HELP, RHI, SMG, FWRD, UNH, JBHT.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

93.66M

Investing Cash Flow (TTM)

269.08M

Financing Cash Flow (TTM)

-57.35M

Free Cash Flow (TTM)

84.03M

Capital Expenditure (TTM)

-9.63M

Net Change in Cash (TTM)

305.39M

Analyst Trends and Forecast

1

Apr

1

1

Jul

1

Aug

2

Sep

1

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$3.12B

PE Ratio (TTM)

32.25

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

7.70

PB Ratio (TTM)

8.15

Earnings Yield % (TTM)

3.10%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

200.28

Price / EBITDA (TTM)

226.60

Price / Free Cash Flow (TTM)

41.96

Book Value / Share

$8.23

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$373.64M

Debt to Equity

0.05

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-